What is Matinas BioPharma Holdings, Inc.'s Market Cap?

Matinas BioPharma Holdings, Inc.'s Market Cap is $25.0M, based on as-reported figures from SEC (XBRL) filings.

What is Matinas BioPharma Holdings, Inc.'s Enterprise Value?

Matinas BioPharma Holdings, Inc.'s Enterprise Value is $24.2M, based on as-reported figures from SEC (XBRL) filings.

What is Matinas BioPharma Holdings, Inc.'s EV / EBITDA?

Matinas BioPharma Holdings, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Matinas BioPharma Holdings, Inc.'s Net Income (TTM)?

Matinas BioPharma Holdings, Inc.'s Net Income (TTM) is -$6.7M, based on as-reported figures from SEC (XBRL) filings.

What is Matinas BioPharma Holdings, Inc.'s EBITDA?

Matinas BioPharma Holdings, Inc.'s EBITDA is -$6.7M, based on as-reported figures from SEC (XBRL) filings.

What is Matinas BioPharma Holdings, Inc.'s Diluted EPS (TTM)?

Matinas BioPharma Holdings, Inc.'s Diluted EPS (TTM) is -0.46, based on as-reported figures from SEC (XBRL) filings.

What is Matinas BioPharma Holdings, Inc.'s Net Debt?

Matinas BioPharma Holdings, Inc.'s Net Debt is -$755.0K, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Matinas BioPharma Holdings, Inc.

XASE · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG005WX2XH7

1.70▼ 0.01 (-0.55%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM): —
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 1.71
Day's Range: 1.69 – 1.78
52-Week Range: 0.15 – 3.15
Volume: 11.3K
Avg Volume: 319.8K

Share Statistics

Shares Outstanding
Employees: 2
Exchange: XASE
Listed: 2014-07-21

Share count as of August 10, 2026

Matinas BioPharma Holdings, Inc. (MTNB) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Matinas BioPharma Holdings, Inc. (MTNB)

What is Matinas BioPharma Holdings, Inc.'s Market Cap?: Matinas BioPharma Holdings, Inc.'s Market Cap is $25.0M, based on as-reported figures from SEC (XBRL) filings.
What is Matinas BioPharma Holdings, Inc.'s Enterprise Value?: Matinas BioPharma Holdings, Inc.'s Enterprise Value is $24.2M, based on as-reported figures from SEC (XBRL) filings.
What is Matinas BioPharma Holdings, Inc.'s EV / EBITDA?: Matinas BioPharma Holdings, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Matinas BioPharma Holdings, Inc.'s Net Income (TTM)?: Matinas BioPharma Holdings, Inc.'s Net Income (TTM) is -$6.7M, based on as-reported figures from SEC (XBRL) filings.
What is Matinas BioPharma Holdings, Inc.'s EBITDA?: Matinas BioPharma Holdings, Inc.'s EBITDA is -$6.7M, based on as-reported figures from SEC (XBRL) filings.
What is Matinas BioPharma Holdings, Inc.'s Diluted EPS (TTM)?: Matinas BioPharma Holdings, Inc.'s Diluted EPS (TTM) is -0.46, based on as-reported figures from SEC (XBRL) filings.
What is Matinas BioPharma Holdings, Inc.'s Net Debt?: Matinas BioPharma Holdings, Inc.'s Net Debt is -$755.0K, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · MTNBAs-filed SEC (XBRL) data